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Summary Haemophilus inﬂuenzae isolates characterized in a previously published
study from the Kingdom of Saudi Arabia were analysed by outer membrane protein
(OMP) proﬁling. Isolates from patients with conﬁrmed respiratory tract infections
were investigated. Antibiotic susceptibility tests in vitro showed 25/129 (19.4%) had
various degrees of reduced susceptibility to ampicillin although all were fully sus-
ceptible to ceftazidime and ciproﬂoxacin. OMP proﬁles of the -lactamase mediated
ampicillin-resistant and -lactamase negative; ampicillin intermediate resistant
strains (BLNAI) isolated were investigated. Dendrograms of scanned SDS—PAGE of
these strains showed 15 different groupings from the 15 non-typable (NTHi) isolates
tested demonstrating a high degree of heterogeneity whereas the 5 Hib isolates
demonstrated signiﬁcantly closer relatedness and were probably clonal. The present
study demonstrates the groupings of H. inﬂuenzae strains by OMP proﬁle analysis
which did not correlate with the -lactamase production ability, BLNAI isolates,
geographical origin or biotype.
© 2008 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
.
oLtd. All rights reserved
ntroductionaemophilus inﬂuenzae is an important cause of
espiratory tract infections accounting for half
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oi:10.1016/j.jiph.2008.08.002f general-practitioner consultations and a quar-
er of all absences from work due to illness
1]. H. inﬂuenzae is the second most frequent
rganism to be isolated from cases of community-
cquired pneumonia in Europe [2] and is a major
athogen in acute exacerbations of chronic bron-
hitis, sinusitis and otitis media [3]. The emergence
nd spread of antibiotic resistance in pathogenic
solates of H. inﬂuenzae is of clinical concern
Sciences. Published by Elsevier Ltd. All rights reserved.
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since they are a frequent cause of a variety
of respiratory tract infections. In Europe and
North America, probably more than 30% of clini-
cal H. inﬂuenzae isolates are ampicillin-resistant
and few oral agents are available that are capa-
ble of eradicating the organisms [2—4]. In the
United States, surveillance series of clinical H.
inﬂuenzae isolates have shown resistance to ampi-
cillin to be as high as 38.9% in 1994—1995 [5]
although the CLSI standards favoured by US clini-
cal laboratories appear to overestimate ampicillin
resistance.
Although resistance may appear lower in Saudi
Arabia despite antibiotics regularly being sold
over the counter [6] antibiotic resistance in
H. inﬂuenzae may be unrecognized because of
questionable accuracy and lack of international
standardization for antimicrobial and -lactamase
test methods. This present study aims to inves-
tigate whether outer membrane protein pattern
analysis would be a useful tool to investigate
the epidemiology of ampicillin-resistant strains of
H. inﬂuenzae.
Materials and methods
Bacterial strains
A total of 129 unique isolates of H. inﬂuenzae
from patients was collected from ﬁve Saudi med-
ical centres (three in Riyadh and two in Jeddah)
in a study period between 1998 and 2000. The
majority (59%) of H. inﬂuenzae isolates were from
the lower respiratory tract and of the 129 H.
inﬂuenzae isolates, 110 (85.3%) were collected
from patients presenting to outpatients clinics and
19 (14.7%) were obtained from patients who were
admitted to the hospital solely because of their
respiratory tract infections as conﬁrmed from indi-
vidual patient hospital ﬁles. Only one isolate per
patient was accepted for the study; the same
samples were used for analysis in the present
study. All isolates were sub-cultured directly onto
chocolate agar slopes and details of patients,
etc. have been reported elsewhere [7]. All iso-
lates were transferred to glycerol broth and stored
at −70 ◦C.
Susceptibility testingSusceptibility to antibiotics was assessed by MIC
determinations using a standard agar dilution
method as described in detail [8] or by the e-test
method [9]. For the former, antibiotics were added
t
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o the Haemophilus test medium (Oxoid Ltd.,
asingstoke, Hampshire, UK) in doubling dilution
o give ﬁnal concentrations ranging from 0.06 to
2g/mL. A multi-point inoculator was used to
eposit approximately 1× 104 CFU per inoculated
pot. All plates were incubated for 18—24 h at 37 ◦C
n an atmosphere containing 5% CO2. The MIC was
eﬁned as the lowest concentration of the agent
hat produced complete inhibition after incubation
t 37 ◦C for 24 h. The reference strain H. inﬂuenzae
TCC 49247 was included. In this study breakpoints
sed to determine susceptibility for H. inﬂuenzae
ere those recommended by the NCCLS [8] namely
mpicillin ≤1g/mL; amoxicillin/clavulanic acid
Augmentin) ≤4/2g/mL; ciproﬂoxacin ≤1g/mL;
eftazidime ≤2g/mL.
erotyping
. inﬂuenzae was tested for the presence of type
capsular antigen by slide agglutination using H.
nﬂuenzae type b speciﬁc antisera and H. inﬂuen-
ae antiserum poly (Difco, Detroit, MI). In the
reviously reported study [7] 7.8% of the strains
solated overall were found to be encapsulated
nd none were recognised as non-b serotypes. All
solates were sub-cultured once onto chocolate
gar slopes directly from the clinical material and
erotyped before longer term storage procedures
ere undertaken to avoid possible in vitro changes
n encapsulation or outer membrane composition.
iotyping
ll -lactamase-positive and BLNAI strains of H.
nﬂuenzae were biotyped [7].
haracterization of -lactamases
-Lactamase production was detected by nitroceﬁn
10] impregnated sticks (Oxoid) A colour change
ithin 5min from yellow to red was taken as a pos-
tive reaction. Negative -lactamase reaction was
etermined as no change in colour within 15min.
urthermore, -lactamase detection for isolates
hat were negative by the nitroceﬁn sticks above
ut showed reduced susceptibility to ampicillin
BLNAI) was tested with Beta-Test strips (Medical
ire and Equipment Co.). A change in the colour ofhe strip from purple to yellow within 5min con-
tituted a positive test. A negative -lactamase
eaction was determined as no change in colour
ithin 15min. H. inﬂuenzae ATCC 49247 was used
s a control
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tnalysis of ampicillin-resistant isolates of Haemoph
ntimicrobial agents
mpicillin (Bristol-Myers Squibb, USA), cef-
azidime, Augmentin (GSK, UK), ciproﬂoxacin
Bayer, Germany) were obtained from the
anufacturers.
MP methodology
uter membrane protein proﬁle analysis was based
n the classic method of van Alphen et al. [11]
rieﬂy, H. inﬂuenzae isolates were grown in 10mL
f broth, cells collected by centrifugation and
ashed in 0.9% NaCl and subsequently disrupted
y sonication. Unlysed cells were removed by
entrifugation and the supernatant subjected to
0,000× g at 4 ◦C. Pellets containing crude cell
nvelopes were re-suspended in 0.5mL of 2mM
ris—HCl buffer (pH 7.2) and stored at −20 ◦C. Pro-
eins were separated by pre-cast polyacrylamide
els (Biorad Laboratories). Cell envelope suspen-
ions (25L) were mixed with 10L of 6× sample
reparation buffer (0.06M Tris—Cl (pH 6.8) 2%
DS, 10% glycerol, 5% 2-mercaptoethanol 0.001%
romophenol blue) and loaded onto gels [11] as
ppropriate.
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Table 1 Isolates with reduced ampicillin susceptibility inv
Lane number Isolate Region MIC (g/Ml amp
(A) NTHi strains
1 KAUH 44 Jeddah 4
2 KFH 62 Jeddah >32
3 KFSH 67 Riyadh 16
4 KKUH 141 Riyadh >32
5 KFSH 147 Riyadh 2
6 KKUH 149 Riyadh >32
7 KAUH 157 Jeddah 4
8 KFSH 176 Riyadh >32
9 KKUH 183 Riyadh >32
10 RKH 184 Riyadh 2
11 KKUH 195 Riyadh >32
12 KKUH 198 Riyadh 2
13 KAUH 209 Jeddah 2
14 RKH 213 Riyadh 2
15 KKUH 214 Riyadh 2
(B) Hib strains
1 KKUH 34 Riyadh 4
2 KKUH 142 Riyadh >32
3 RKH 224 Riyadh >32
4 RKH226 Riyadh >32
5 KFSH 228 Riyadh >32
6 KKUH 214 Riyadh 2inﬂuenzae 47
esults
usceptibility of isolates
IC values obtained previously [7] showed that
ost (80.6%) of isolates tested were sensitive
o ampicillin. All of the isolates tested by agar
ICs were fully susceptible to ceftazidime, and
iproﬂoxacin although 25 of the 129 isolates demon-
trated reduced susceptibility to ampicillin (further
etails of the susceptibility of our strains of
. inﬂuenzae to various antimicrobials has been
eported previously [7])
erotyping, biotyping and -lactamase
roduction by H. inﬂuenzae
he 17 isolates found to be highly resistant to
mpicillin (MICs, ≥4g/mL), all produced TEM-
-lactamase, the most frequently encountered
ype. The distribution of isolates producing -
actamase ranged from 10% in Jeddah (2 hospitals)
o 14.6% in Riyadh (3 hospitals) (see Ref. [7])
mong the 17 ampicillin-resistant TEM-1 produc-
ng strains, 4 (23.5%) were encapsulated serotype
. Biotypes I, II and III accounted for 94.3% of
he -lactamase-positive strains; of these 35 and
7% belonged to biotypes I and II respectively.
estigated by SDS—PAGE
icillin) Capsular type Biotype -Lactamase
NTHi III Positive
NTHi IV Positive
NTHi I Positive
NTHi I Positive
NTHi III Negative
NTHi III Positive
NTHi I Positive
NTHi I Positive
NTHi I Positive
NTHi II Negative
NTHi II Positive
NTHi IV Negative
NTHi III Negative
NTHi II Negative
NTHi II Negative
Hib II Positive
Hib II Positive
Hib II Positive
Hib II Positive
Hib II Positive
NTHi II Negative
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TFigure 1 Dendrogram constructed from outer membrane
zae NTHi isolates analysed by SDS—PAGE (details in Table
A number of the total strains tested (8 of 129),
demonstrated reduced susceptibility to ampicillin
(MIC = 2g/mL) but failed to produce detectable
-lactamase. These were categorized as BLNAI
strains. Of these, 2 strains were BLNACR demon-
strating resistance to amoxicillin/clavulanic acid
(MICs≥ 8/4g/mL).Outer membrane protein proﬁles of H.
inﬂuenzae
Table 1 shows details of the 15 NTHi isolates
and 5 Hib isolates investigated by SDS—PAGE.
l
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Figure 2 Dendrogram constructed from outer membrane pro
zae Hib isolates and 1 NTHi strain analysed by SDS—PAGE (detein proﬁles showing relationships between 15 H. inﬂuen-
igs. 1 and 2 show dendrograms constructed from
el analysis software -Phoretix 1D version 4.1
Phoretix International, Newcastle) from scanned
hotographs of SDS—PAGE gels. Using the software,
anes were identiﬁed, the background subtracted
nd bands detected automatically. Matching was
chieved by construction of a synthetic lane and
omparing relatedness between bands in lanes.
he results in Fig. 1 show a high degree of dissimi-
arity between 15 ampicillin-resistant isolates of H.
nﬂuenzae which had been serotyped as NTHi. Nine
f these isolates were -lactamase positive and
he other 6 BLNAI. In total, the 15 strains analysed
tein proﬁles showing relationships between 5 H. inﬂuen-
ails in Table 1).
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[nalysis of ampicillin-resistant isolates of Haemoph
rouped into 15 separate clusters indicating a high
evel of heterogeneity amongst the NTHi strains
ested. Five isolates of the Hib type were tested
nd compared to NTHi. The SDS—PAGE proﬁle of
he NTHi strain was clearly distinct from the 5 Hib
trains tested (Fig. 2).
iscussion
n the present investigation we have studied the
pidemiology of ampicillin-resistant clinical strains
f H. inﬂuenzae. Outer membrane protein proﬁling
as been shown to be highly discriminatory in bac-
erial populations and has been used extensively
n the investigation of H. inﬂuenzae outbreaks
11—13]. In our study, we have differentiated
he ampicillin-resistant strains of H. inﬂuenzae
nto two major categories by OMP analysis. The
on-typable isolates were more variable than the
erotype b strains—–the NTHi strains demonstrated
iverse OMP proﬁles, suggesting that they are more
eterogeneous in nature compared with Hib strains
hich have a strong clonal structure. The analysis
f Hib strains by OMP proﬁle analysis did not corre-
ate with the -lactamase production, geographical
rigin or biotype although in contrast to the analysis
y ERIC-PCR previously reported [14] the major-
ty of these strains were generally not found to
e identical. In addition, serologically non-typable
trains (NTHi) analysed by their OMP proﬁles also
id not correlate with either -lactamase produc-
ion ability, BLNAI or BLNACR types, geographical
rigin or biotype. Surveillance studies using OMP
roﬁle analysis of NTHi agrees with other stud-
es on the considerable heterogeneity among these
trains, and conﬁrms the work of van Alphen et al.
11] who compared the OMP subtypes of antibiotic
esistant and sensitive strains and found a similar
istribution. BLNAI and BLNACR strains in our col-
ection did not show any unique clustering and the
roﬁles produced for these strains were not differ-
nt from other NTHi strains.
onclusions
his is the ﬁrst report of OMP analysis of serotype
and non-typable strains isolated from conﬁrmed
linical cases in Saudi Arabia although interna-
ional isolates including Indian strains have been
nvestigated previously [13]. NTHi subtyping by
uter membrane protein analysis has proved useful
or investigating the transmission of H. inﬂuen-
ae and re-infection epidemiology studies with
[
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atients over time [15] but we have shown in
his study that sub-typing appears less useful for
apid tracking/surveillance of ampicillin-resistant
. inﬂuenzae in populations.
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